comparemela.com

Latest Breaking News On - Markj gallardo - Page 1 : comparemela.com

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today. | May 1, 2023

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Catar

ALISO VIEJO, Calif. (BUSINESS WIRE) Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its technologies will be featured in various scientific programmin.

Targeted News Service

Targeted News Service
targetednews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from targetednews.com Daily Mail and Mail on Sunday newspapers.

Sight Sciences Announces Multiple Presentations at the 2021

© 2021 Sight Sciences. All rights reserved. Forward-Looking Statements This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. When used herein, words including “anticipate,” “will,” and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking. All forward-looking statements are based upon Sight Sciences’ current expectations and various assumptions. Actual results, levels of activity, performance, achievements and events could differ materially from those stated, anticipated or implied by such forward-looking statements. While the Company believes that its assumptions are reasonable, Sight Sciences may not realize its expectations, and

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.